Raquel RD Moreira a, Caio H Perego a, André G dos Santos a, Flávio Alexandre de Carvalho a, Carlos Cavaleiro b, Lígia Salgueiro b, Maria do Céu Sousa b, Mara Lane C Cardoso c, Juliana Cogo c, Celso V Nakamura c. Comunicación en forma de póster en el 9º Congreso de Fitoterapia de SEFIT – IX Jornada Farmacéutica de la Isla del Rey, Menorca, 18-21 de mayo de 2017
a UNESP-Univ. Estadual Paulista, Faculdade de Ciências Farmacêuticas de Araraquara, Araraquara, São Paulo, Brasil. b Universidade de Coimbra, Faculdade de Farmácia, Portugal c Universidade Estadual de Maringá, Maringá, Paraná, Brasil.

Tagetes patula. Foto: Rajat0247 (licencia CC)
Introduction
Leishmaniosis is an important public-health problem, manifested in visceral, mucocutaneous, or cutaneous forms. Leishmania amazonensis causes cutaneous leishmaniasis, which ranges from small cutaneous nodules to gross mucosal tissue destruction. The drugs recommended currently for treatment include pentavalent antimonials, amphotericin B, and miltefosine. But, are limited to some extent by their toxicity, lack of efficacy, requirement for hospitalisation, or cost. More efficacious drugs are urgently needed to treat patients with leishmaniasis. So, is urgent the search for new drugs against Leishmania spp. Essential oils (EOs) are a potential source for new antiprotozoal drugs, and can contribute to overcome the drug resistance of protozoan parasites.
[Leer más…]








Viola cornuta. Foto: Xemenendura (licencia CC)

